The Joint, headquartered in Scottsdale, Arizona, operates approximately 135 corporate clinics and 800 franchises, employing 444 staff. The company went public on November 11, 2014, offering wellness packages and digital record management.
Based on our analysis, Joint is currently rated as overvalued by Cashu, receiving a 1 out of 5 stars. Several key financial ratios indicate that the company is not performing as well as its sector, which raises concerns regarding its valuation.
One of the critical metrics is the Price-to-Book (PB) Ratio, which stands at 9.37, significantly higher than the sector average of 2.71. A high PB ratio may suggest that investors are paying too much for each dollar of net assets, implying that the stock price may be inflated relative to its actual value.
Additionally, Joint's Return on Equity (ROE) Ratio is -47.39, compared to the sector's -76.41. While both figures are negative, Joint's less favorable ROE indicates that the company is generating far less profit from its shareholders’ equity than its peers, suggesting inefficiencies in utilizing shareholder funds.
The Return on Assets (ROA) Ratio for Joint is -10.66, against a sector average of -47.59. Although Joint's negative ROA is better than the sector, it still reflects poor asset management, indicating that the company is struggling to convert its assets into profitable returns effectively.
These ratios collectively highlight that Joint is facing significant operational challenges that may have led to its overvaluation in the market. Investors should carefully consider these factors before making any decisions related to Joint.
This is not a comprehensive overview of our valuation, and should not be viewed as financial advice. Always do your own research before considering an investment.
📡️ Health Care
Overvalued
More Signals
Feature in Progress
This section is under development. Check back soon for updates!